Objectives: To explore the therapeutic effect of myofascial trigger point electroacupuncture technology on treating female overactive bladder syndrome.
Methods: Forty female patients with overactive bladder were randomly divided into 2 groups: an experimental group and a control group. The experimental group was treated with myofascial trigger point electroacupuncture therapy combined with solifenacin succinate while the control group was only treated with solifenacin succinate. Patients in both groups were treated for 12 weeks. The overactive bladder symptom score (OABSS), urinary urgency score and urination frequency of 24 h in the 2 groups were compared to analyze the therapeutic effect.
Results: Before the comprehensive treatment, there was no significant difference between the experimental group and the control group (P>0.05). After 2 and 12 weeks of continuous treatment, the OABSS, urinary urgency symptoms score and 24 h urination frequency in the experimental group and the control group were lower than those before the treatment, and the degree of decline in the experimental group was more obvious, with significant difference (P<0.05).
Conclusions: Treating overactive bladder syndrome in women with myofascial trigger point electroacupuncture combined with solifenacin succinate can significantly improve the OABSS and improve the life quality of the patients.
目的: 探讨电针刺激肌筋膜触发点治疗女性膀胱过度活动症的临床疗效。方法: 选择40例女性膀胱过度活动症患者为研究对象，分为试验组和对照组，各20例。试验组给予电针刺激肌筋膜触发点联合索利那新治疗，对照组单纯给予索利那新治疗，评估两组治疗前、治疗后2周及12周的膀胱过度活动症症状评分(overactive bladder symptom score，OABSS)、尿急症状评分和24 h排尿次数。结果: 治疗前，试验组及对照组OABSS、尿急症状评分和 24 h排尿次数差异均无统计学意义(P>0.05)。持续治疗2周及12周后，试验组和对照组的OABSS、尿急症状评分和24 h排尿次数均有下降，且治疗后12周临床指标下降程度更明显(P<0.05)。与对照组比较，试验组治疗2周及12周临床指标下降程度更加明显，差异均有统计学意义(P<0.05)。结论: 电针刺激肌筋膜触发点治疗女性膀胱过度活动症，可以显著改善患者OABSS，提高患者的生活质量。.
Keywords: electroacupuncture; myofascial trigger point; overactive bladder syndrome; overactive bladder syndrome score.